[go: up one dir, main page]

Liu et al., 2018 - Google Patents

Water‐Soluble Conjugated Polymers for Sensing and Imaging Applications

Liu et al., 2018

Document ID
6896333945526629740
Author
Liu X
Huang W
Fan Q
Publication year
Publication venue
Conjugated Polymers for Biological and Biomedical Applications

External Links

Snippet

Conjugated polymers (CPs) with large n‐conjugated backbones and delocalized electronic structures exhibit efficient coupling between opto‐electronic segments, and have been widely applied in opto‐electronic devices in the past decade. Meanwhile, water‐soluble …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles

Similar Documents

Publication Publication Date Title
Mo et al. Cadmium-containing quantum dots: properties, applications, and toxicity
Zhang et al. Carbon dots: large-scale synthesis, sensing and bioimaging
Wegner et al. Quantum dots: bright and versatile in vitro and in vivo fluorescence imaging biosensors
Zhang et al. Carbon dots-embedded epitope imprinted polymer for targeted fluorescence imaging of cervical cancer via recognition of epidermal growth factor receptor
Yao et al. Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy
Thiruppathi et al. Nanoparticle functionalization and its potentials for molecular imaging
Zheng et al. Recent advances in drug release monitoring
Yu et al. Recent advances in the development of highly luminescent semiconducting polymer dots and nanoparticles for biological imaging and medicine
Jiang et al. Surface-functionalized nanoparticles for biosensing and imaging-guided therapeutics
Jiang et al. Optical imaging-guided cancer therapy with fluorescent nanoparticles
Davodabadi et al. Aptamer‐functionalized quantum dots as theranostic nanotools against cancer and bacterial infections: a comprehensive overview of recent trends
Zhang et al. Mn2+ complex-modified polydopamine-and dual emissive carbon dots based nanoparticles for in vitro and in vivo trimodality fluorescent, photothermal, and magnetic resonance imaging
Delehanty et al. Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery
Kim et al. Gold nanoparticles in image-guided cancer therapy
Wang et al. Bioconjugated silica nanoparticles: development and applications
Arap et al. Luminescent silica nanoparticles for cancer diagnosis
Xu et al. Advances and perspectives in near‐infrared fluorescent organic probes for surgical oncology
Yang et al. Fluorescent hybrid silica nanoparticles and their biomedical applications
Wang et al. The synthesis and bio-applications of magnetic and fluorescent bifunctional composite nanoparticles
Feng et al. Fluorescence bioimaging with conjugated polyelectrolytes
Zhang et al. Supramolecular hybrids of AIEgen with carbon dots for noninvasive long-term bioimaging
Kamila et al. Diagnostic and therapeutic applications of quantum dots in nanomedicine
Mahajan et al. Magnetic quantum dots in biotechnology–synthesis and applications
Nguyen et al. Upconversion nanoparticles in bioassays, optical imaging and therapy
Sobhanan et al. Nanomaterials for fluorescence and multimodal bioimaging